Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes

The possibility of using gene therapy for the treatment of cancer is limited by the lack of safe, intravenously administered delivery systems able to selectively deliver therapeutic genes to tumors. In this study, we investigated if the conjugation of the polypropylenimine dendrimer to lactoferrin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Li Ying, Koh, Pei Yin, Somani, Sukrut, Al Robaian, Majed, Karim, Reatul, Yean, Yi Lyn, Mitchell, Jennifer, Tate, Rothwelle J., Edrada-Ebel, RuAngelie, Blatchford, David R., Mullin, Margaret, Dufès, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509555/
https://www.ncbi.nlm.nih.gov/pubmed/25933695
http://dx.doi.org/10.1016/j.nano.2015.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509555/
https://www.ncbi.nlm.nih.gov/pubmed/25933695
http://dx.doi.org/10.1016/j.nano.2015.04.006

Ejemplares similares